1. Home
  2. OLMA vs SLRC Comparison

OLMA vs SLRC Comparison

Compare OLMA & SLRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • SLRC
  • Stock Information
  • Founded
  • OLMA 2006
  • SLRC 2007
  • Country
  • OLMA United States
  • SLRC United States
  • Employees
  • OLMA N/A
  • SLRC N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • SLRC Finance/Investors Services
  • Sector
  • OLMA Health Care
  • SLRC Finance
  • Exchange
  • OLMA Nasdaq
  • SLRC Nasdaq
  • Market Cap
  • OLMA 725.5M
  • SLRC 771.9M
  • IPO Year
  • OLMA 2020
  • SLRC 2010
  • Fundamental
  • Price
  • OLMA $8.72
  • SLRC $15.48
  • Analyst Decision
  • OLMA Strong Buy
  • SLRC Hold
  • Analyst Count
  • OLMA 6
  • SLRC 6
  • Target Price
  • OLMA $23.00
  • SLRC $15.96
  • AVG Volume (30 Days)
  • OLMA 1.5M
  • SLRC 339.6K
  • Earning Date
  • OLMA 11-07-2025
  • SLRC 11-04-2025
  • Dividend Yield
  • OLMA N/A
  • SLRC 10.72%
  • EPS Growth
  • OLMA N/A
  • SLRC N/A
  • EPS
  • OLMA N/A
  • SLRC 1.63
  • Revenue
  • OLMA N/A
  • SLRC $222,445,000.00
  • Revenue This Year
  • OLMA N/A
  • SLRC N/A
  • Revenue Next Year
  • OLMA N/A
  • SLRC $0.23
  • P/E Ratio
  • OLMA N/A
  • SLRC $9.51
  • Revenue Growth
  • OLMA N/A
  • SLRC N/A
  • 52 Week Low
  • OLMA $2.86
  • SLRC $13.64
  • 52 Week High
  • OLMA $13.51
  • SLRC $17.94
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 47.84
  • SLRC 60.28
  • Support Level
  • OLMA $7.80
  • SLRC $13.95
  • Resistance Level
  • OLMA $8.48
  • SLRC $14.72
  • Average True Range (ATR)
  • OLMA 0.76
  • SLRC 0.30
  • MACD
  • OLMA -0.31
  • SLRC 0.19
  • Stochastic Oscillator
  • OLMA 44.15
  • SLRC 93.29

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About SLRC SLR Investment Corp.

SLR Investment Corp is a closed-end externally managed, non-diversified management investment company that has elected to be treated as a business development company. It provides U.S. middle market businesses and intermediaries with bespoke debt financing solutions to fund working capital, acquisition, refinancing and growth capital requirements. It invests majorly in leveraged middle-market companies in the form of senior secured loans, financing leases and to a lesser extent, unsecured loans and equity securities.

Share on Social Networks: